The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli
Open accessAbstract
Extraintestinal pathogenic Escherichia coli (ExPEC) are a common cause of disease in both mammals and birds. A vaccine to prevent such infections would be desirable given the increasing antibiotic resistance of these bacteria. We have determined the genome sequence of ExPEC IHE3034 (ST95) isolated from a case of neonatal meningitis and compared this to available genome sequences of other ExPEC strains and a few nonpathogenic E. coli . We found 19 genomic islands present in the genome of IHE3034, which are absent in the nonpathogenic E. coli isolates. By using subtractive reverse vaccinology we identified 230 antigens present in ExPEC but absent (or present with low similarity) in nonpathogenic strains. Nine antigens were protective in a mouse challenge model. Some of them were also present in other pathogenic non-ExPEC strains, suggesting that a broadly protective E. coli vaccine may be possible. The gene encoding the most protective antigen was detected in most of the E. coli isolates, highly conserved in sequence and found to be exported by a type II secretion system which seems to be nonfunctional in nonpathogenic strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The complete genome sequence of Escherichia coli K-12.
Blattner, F., Plunkett, G., Bloch, C., Perna, N., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C., Mayhew, G., et al. (1997) · Science · doi:10.1126/science.277.5331.1453 · Cited by 7,996
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Sex and virulence in Escherichia coli : an evolutionary perspective
Wirth, T., Falush, D., Lan, R., Colles, F. M., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. J., Ochman, H., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05172.x · Cited by 2,075
Self-citationWelch, R. A., Burland, V., Plunkett, G., Redford, P., Roesch, P. L., Rasko, D. A., Buckles, E. L., Liou, S., Boutin, A., Hackett, J. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252529799 · Cited by 1,523
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,403
Self-citationOrganised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths
Touchon, M., Hoede, C., Tenaillon, O., Barbe, V., Baeriswyl, S., Bidet, P., Bingen, É., Bonacorsi, S., Bouchier, C., Bouvet, O. M. M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000344 · Cited by 1,248
Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188
Self-citationRusso, T. A., & Johnson, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00049-2 · Cited by 801
Expert system for predicting protein localization sites in gram‐negative bacteria
Nakai, K., & Kanehisa, M. I. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340110203 · Cited by 756
Gardy, J. L., Laird, M. R., Chen, F., Rey, S., Walsh, C. J., Ester, M., & Brinkman, F. S. L. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bti057 · Cited by 719
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–261 of 261
Structural characterization of the Sel1‐like repeat protein LceB from Legionella pneumophila
Penner, T. V., Cobo, N. L., Patel, D. T., Patel, D., Savchenko, A. V., Brassinga, A. K. C., & Prehna, G. (2023) · Protein Science · doi:10.1002/pro.4889 · Cited by 4
Prieto, A., Miró, L., Margolles, Y., Bernabeu, M., Salguero, D., Merino, S., Tomás, J. M., Sánchez, J. A. C., Pérez‐Bosque, A., Hüttener, M., et al. (2024) · eLife · doi:10.7554/elife.95328 · Cited by 4
Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies
Palanikumar, P., Nathan, B., Muthusamy, K., Suganthy, M., Senthil, N., & Sampathrajan, V. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05182-8 · Cited by 4
Structure-Based Peptide Mimicry of Tumor-Associated Antigens
Ohtaki, A., Kieber‐Emmons, T., & Murali, R. (2013) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2012.0076 · Cited by 4
Ma, Q., Chen, X., Liu, C., Mao, X., Zhang, H., Ji, F., Wu, C., & Xu, Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4734-y · Cited by 4
Westcott, M. M., Morse, A. E., Troy, G., Blevins, M. W., Wierzba, T. F., & Sanders, J. W. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03661-23 · Cited by 3
Misconceptions About the Bioarchaeology of Plague
DeWitte, S. N. (2018) · Bioarchaeology and social theory · doi:10.1007/978-3-319-93012-1_5 · Cited by 3
Habibi, M., Azimi, S., Khoobbakht, D., Roghanian, P., & Karam, M. R. A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107638 · Cited by 3
Chakraborty, J., & Chatterjee, R. (2022) · Bioscience Reports · doi:10.1042/bsr20212084 · Cited by 3
Pathogen-Omics: Challenges and Prospects in Research and Clinical Settings
Purkait, D., Hameed, S., & Fatima, Z. (2021) · Springer eBooks · doi:10.1007/978-981-16-0691-5_28 · Cited by 3
Bacterial Genomes and Vaccine Design
Cafardi, V., Telford, J. L., & Serruto, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5070-2_2 · Cited by 3
Vaccinology Is Turning into an Omics‐Based Science
Prachi, P., Biagini, M., & Bagnoli, F. (2012) · Drug Development Research · doi:10.1002/ddr.21048 · Cited by 4
Considerations for Vaccine Design in the Postgenomic Era
Maritz-Olivier, C., & Richards, S. A. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_16 · Cited by 2
Unconventional Cyclic di-GMP Signaling in Escherichia coli
Zlatkov, N., & Uhlin, B. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33308-9_29 · Cited by 2
Meningitis-associated Escherichia coli
Kim, K. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397048-0.00010-3 · Cited by 2
Microbiota and the Urogenital Tract, Pathogenesis, and Therapies
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00014-4 · Cited by 2
Deep characterization of Escherichia coli in a cohort of mothers and their infants
de Muinck, & Jacques, É. (2013) · Cited by 2
Sequence alignment with k -bounded matching statisticsPreprint
Mäklin, T., Alanko, J., Biagi, E., & Puglisi, S. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.19.654936 · Cited by 2
Muhammad, J., Muaz, M., Bako, G. D., Musa, B., & Zubair, M. I. (2025) · UMYU Journal of Microbiology Research (UJMR) · doi:10.47430/ujmr.25103.034 · Cited by 1
Adaptive Immune Responses to Infection and Opportunities for Vaccine Development (Rickettsiaceae)
Valbuena, G. (2014) · ASM Press eBooks · doi:10.1128/9781555817336.ch10 · Cited by 1
Therapeutics and Vaccines Against Pathogenic Escherichia coli
Palermo, M. S., Flores‐Figueroa, J., & Paredes‐Paredes, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45092-6_11 · Cited by 1
Galv´an, H. E. D., López, H. M., Ramos, E. M., Yepes-Blandón, J. A., Campo, O., Torres, K. N. Q., Tirado, L. C. E., & Julio, R. G. V. (2023) · Revista Colombiana de Biotecnología · doi:10.15446/rev.colomb.biote.v25n2.110727 · Cited by 1
Recent Insights into the Synthesis of Oligosaccharides from Escherichia coli: Review
Sharma, A., Rabha, P., & Panchadhayee, R. (2024) · Current Organic Chemistry · doi:10.2174/0113852728322510240711045944 · Cited by 1
Khalid, H., & Shityakov, S. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00288-z · Cited by 1
Design of New Vaccines in the Genomic and Post-genomic Era
Serino, L., Seib, K. L., & Pizza, M. (2012) · Springer eBooks · doi:10.1007/978-94-007-4543-8_1 · Cited by 1
Self-citationNew Approaches for Needed Vaccines: Bacteria
MacLennan, C. A., Mutreja, A., & Gordon Dougan, B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802174-3.00016-3 · Cited by 1
Population Phylogenomics of Extraintestinal PathogenicEscherichia coli
Tourret, J., & Denamur, É. (2016) · ASM Press eBooks · doi:10.1128/9781555817404.ch11 · Cited by 1
To Move or to Convene : Regulatory Circuits of Mat Fimbriae in Escherichia coli
Lehti, T. A. (2012) · Työväentutkimus Vuosikirja · Cited by 1
Phylogenetic and genomic characterization of porcine enterotoxigenic Escherichia coli
Shepard, S. M. (2011) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Gunathilake, K. K., Dewasmika, P., Sandaruwan, M., Neelawala, D., Madhumali, D., Dissanayake, N., Priynatha, R., Prasada, P. V. P., & Dissanayake, D. A. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4601825 · Cited by 1
Microbial Vaccine Design: The Reverse Vaccinology Approach
Rosini, R., Barocchi, M. A., & Rappuoli, R. (2011) · doi:10.1002/9781118023648.ch1
Self-citationRogers, M. T. (2012) · ScholarWorks - WMU (Western Michigan University)
Characterization of a novel Escherichia coli IgA-binding antigen impairing neutrophil activation
Pastorello, I. (2012) · Padua Research Archive (University of Padova)
Self-citationNandanwar, N. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14004
Dorrington, E., Kelly, K., Mackay, M., & Pedwell, R. K. (2013)
Tapader, R., & Pal, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8763-0_19
Las partículas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunología
Ganzó, A. D., Borio, C. S., Pastorini, M., Lozano, M. E., & Goñi, S. E. (2018) · Divulgatio Perfiles académicos de posgrado · doi:10.48160/25913530di05.58
Rationales for including adjuvants in vaccines
Schijns, V. E. C. J., & Lavelle, E. C. (2011) · doi:10.2217/ebo.11.10
Vaccine Design Strategies: Pathogens to Genomes
McMullan, N. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788017862-00440
Artificial Intelligence and Machine Learning for Prediction and Analysis of Genomic Islands
Shukla, A., Mishra, N. K., & Choudhary, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-9342-8_17
Rodrigues, T. C. V., Jaiswal, A. K., Aburjaile, F. F., Almeida, C. A., Carvalho, R. D. D. O., de Paula, J. A., Santos, R. P. S., Dominici, F. V., Felice, A. G., Marques, P. H., et al. (2023) · Springer eBooks · doi:10.1007/978-981-19-9342-8_3
Xing, Y., Clark, J. R., Chang, J. D., Zulk, J. J., Chirman, D. M., Piedra, F.-A., Patras, K. A., & Maresso, A. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.31.543151
Prieto, A., Miró, L., Margolles, Y., Bernabeu, M., Salguero, D., Merino, S., Tomás, J. M., Sánchez, J. A. C., Pérez‐Bosque, A., Hüttener, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.12.571265
Prieto, A., Miró, L., Margolles, Y., Bernabeu, M., Salguero, D., Merino, S., Tomás, J. M., Sánchez, J. A. C., Pérez‐Bosque, A., Hüttener, M., et al. (2024) · eLife · doi:10.7554/elife.95328.1
Prieto, A., Miró, L., Margolles, Y., Bernabeu, M., Salguero, D., Merino, S., Tomás, J. M., Sánchez, J. A. C., Pérez‐Bosque, A., Hüttener, M., et al. (2024) · eLife · doi:10.7554/elife.95328.2
A descriptor-free machine learning framework to improve antigen discovery for bacterial pathogens
Podda, M., Savojardo, C., Martelli, P. L., Casadio, R., Sîrbu, A., Priami, C., & Brozzi, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323895
Monitoring of vaccine targets and interventions using global genome data: vaccines.watchPreprint
David, S., Abudahab, K., Couto, N., Daningrat, W. O. D., Yeats, C., Molloy, A., Ashton, P., Alikhan, N.-F., & Aanensen, D. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.13.659488 · Cited by 1
Riaz, S., Steinsland, H., Boysen, A., & Hanevik, K. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00748-7 · Cited by 1
Maldonado, N. A., López-Hernández, I., Valik, J. K., López-Cortés, L. E., Pérez-Crespo, P. M. M., García-Montaner, A., Alcalde‐Rico, M., Sousa-Domínguez, A., Jover-Sáenz, A., Goikoetxea, J., et al. (2026) · Communications Medicine · doi:10.1038/s43856-025-01364-x
Li, Z., Ma, G., Liu, R. T., Wang, X., Wang, Y., Zhao, X., Meng, Q., Xie, L., Li, X., Liu, S., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125009
Martins, T. W., Trotereau, A., Lahnig-Jacques, S., Branger, M., Houle, S., Dozois, C. M., Pavanelo, D. B., Horn, F., & Schouler, C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342894
Wang, Y., Liu, H., Wang, Y., Wang, B., Fang, X., Wang, H., Liu, L., & Tan, H. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00829
Ageorges, V. (2019) · theses.fr (ABES) · doi:10.70675/7e01e369zc5bez4125za868zb6fea14dddc5
Architecture of the type II secretion systemPreprint
Tayebinia, M., Ghanem, N., Zhang, H., Yang, Y., Fornili, A., Shevchik, V. E., Dabari, V., & Pickersgill, R. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.07.723501
Ren, J., Qin, H., Yan, W., Qi, Y., Du, D., Wang, P., Yan, W., & Jiang, J. (2026) · Microorganisms · doi:10.3390/microorganisms14071586
Revisiting the type II secretion system: it is more than you might think
Cianciotto, N. P., Mayoral, J., & Garnett, J. A. (2026) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00118-25
Kamdar, M., Shah, V., Janssen, S., Domínguez, E. G., Davies, T. A., & van den Dobbelsteen, G. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00863-26
Metadata
- Authors
- Moriel, D. G., Bertoldi, I., Spagnuolo, A., Marchi, S., Rosini, R., Nesta, B., Pastorello, I., Corea, V. A. M., Torricelli, G., Cartocci, E., Savino, S., Scarselli, M., Dobrindt, U., Hacker, J., Tettelin, H., Tallon, L. J., Sullivan, S., Wieler, L. H., Ewers, C., Pickard, D., Dougan, G., Fontana, M. R., Rappuoli, R., Pizza, M., & Serino, L.
- Affiliations
- Novartis (Italy) (IT)
- University of Würzburg (DE)
- University of Maryland, Baltimore (US)
- J. Craig Venter Institute (US)
- Freie Universität Berlin (DE)
- Wellcome Sanger Institute (GB)
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-05-03
- Volume
- 107
- Issue
- 20
- Pages
- 9072-9077
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889118
- OpenAlex
- W1972223538
- Cited by
- 261
- References
- 54
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 4 · 2021: 15 · 2020: 18 · 2019: 10 · 2018: 20 · 2017: 10 · 2016: 28 · 2015: 19 · 2014: 20 · 2013: 28 · 2012: 26
- FWCI
- 15.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Bundesministerium für Bildung und Forschung (01KI07120)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Keywords
- extraintestinal pathogenic Escherichia coli, vaccine antigens, genomic islands, neonatal meningitis, ST95, type II secretion system, conserved antigens, mouse challenge protection, genome sequence
- MeSH terms
- Animals, Antigens, Bacterial, Base Sequence, Escherichia coli, Escherichia coli Infections, Finland, Humans, Molecular Sequence Data, Genome, Bacterial, Sequence Analysis, DNA, Computational Biology, Meningitis, Escherichia coli, Escherichia coli Vaccines, Genomic Islands, Mice, Secretory Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review